(Q36256185)

13 August 2017

title

Aripiprazole in children and adolescents: clinical experience (English)

1 reference

13 August 2017

1 reference

Thomas A Rugino

1

1 reference

13 August 2017

Yvette M Janvier

series ordinal

2

1 reference

13 August 2017

publication date

1 July 2005

1 reference

Journal of Child Neurology

13 August 2017

published in

1 reference

13 August 2017

volume

20

1 reference

13 August 2017

issue

7

1 reference

13 August 2017

page(s)

603-610

1 reference

A systematic review of the use of atypical antipsychotics in autism

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Risperidone in children with autism and serious behavioral problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Atypical antipsychotic drug use and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Aripiprazole: A New Atypical Antipsychotic Drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

A case series of eight aggressive young children treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200071301

10.1177/08830738050200071301

21 January 2018

Identifiers

DOI

0 references

1 reference